Does Ozempic Wegovy Blindness Affect your Eyesight? Here The Risks!

--

Game, OTONITY - A new study, which appeared in JAMA OphthalmologyTrusted Source earlier this week, identified a potential link between the diabetes and weight loss drug, semaglutide and a rare eye disease that causes blindness.

The condition, called nonarteritic anterior ischemic optic neuropathy (NAION), affects around 2.3 people per 100,000Trusted Source people in the United States.

Read more: Uncensored! Soy La Oruga Video Viral Full Duration! Uncut Trending on Tiktok Twitter!

Read more: Video Link Jamie Marr Sketch Onlyfans Viral Tiktok Twitter, Full Duration Uncensored Download HD!

The new study finds that people with diabetes who were prescribed semaglutide — which is marketed as Ozempic and Wegovy, among other names — were more than four times more likely to develop NAION compared with people with diabetes on other medications.

Similarly, those who were prescribed the drug to treat overweight or obesity were over seven times more likely to receive a NAION diagnosis than people taking other weight loss drugs.

The rate of the eye problem known as nonarteritic anterior ischemic optic neuropathy, or NAION, was 8.9% for those taking semaglutide for type 2 diabetes, compared with 1.8% for patients taking non-GLP-1 diabetes medications, researchers reported in JAMA Ophthalmology.

Read more: What Is Wandsworth Prison Guard Real Video Leak ? Having Sex With Prisioner, and Making the Public Lose Trust!